drugset / Trial / NCT00867451

Improving Sleep and Daytime Functioning Among Children Diagnosed With Attention Deficit Hyperactivity Disorder (ADHD)

NCT00867451

Phase 1/2 Completed 8 enrolled Children's Hospital Medical Center, Cincinnati
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will test the efficacy of a systematic, multi-modal intervention protocol designed to improve sleep functioning and subsequent alleviation of daytime cognitive and behavioral difficulties among children diagnosed with ADHD. It is hypothesized that children receiving behavioral and (if necessary) pharmacologic interventions targeting sleep will display improvement on objective and subjective sleep measures, neuropsychological tests, and teacher-, and parent-ratings of ADHD behaviors.

Timeline

Start
2010-01
Primary completion
2011-06
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 3 mg
Subject Melatonin Small molecule 6 mg